2020
DOI: 10.1186/s12986-020-00513-4
|View full text |Cite
|
Sign up to set email alerts
|

Chronic stress, epigenetics, and adipose tissue metabolism in the obese state

Abstract: In obesity, endocrine and metabolic perturbations, including those induced by chronic activation of the hypothalamus–pituitary–adrenal axis, are associated with the accumulation of adipose tissue and inflammation. Such changes are attributable to a combination of genetic and epigenetic factors that are influenced by the environment and exacerbated by chronic activation of the hypothalamus–pituitary–adrenal axis. Stress exposure at different life stages can alter adipose tissue metabolism directly through epige… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
27
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 43 publications
(29 citation statements)
references
References 153 publications
(199 reference statements)
2
27
0
Order By: Relevance
“…Among them, leptin (LEP), a peptide hormone mainly released from WAT, mediates a complex communication between the intestine, adipose tissue and the brain, leading to reduced food consumption and enhanced energy expenditure, thus regulating body weight homeostasis [ 46 ]. Even though the increase of adipose tissue mass in obesity increases production of leptin, soluble leptin receptors (LEPRs, the main leptin binding proteins in circulation that result from LEPR cleavage and regulate leptin function and bioavailability) decrease, while leptin transport into the central nervous system (CNS) is not commensurately increased, resulting in decreased hypothalamic leptin signaling, increased leptin levels and leptin resistance [ 47 , 48 , 49 , 50 ]. Adiponectin, another adipocyte-specific hormone, actually the most abundant adipocytokine in plasma and ubiquitously expressed in adipose tissue [ 10 ], displays anti-inflammatory and antifibrotic properties in many organs [ 51 , 52 , 53 ].…”
Section: Adipose Tissue Physiologymentioning
confidence: 99%
See 3 more Smart Citations
“…Among them, leptin (LEP), a peptide hormone mainly released from WAT, mediates a complex communication between the intestine, adipose tissue and the brain, leading to reduced food consumption and enhanced energy expenditure, thus regulating body weight homeostasis [ 46 ]. Even though the increase of adipose tissue mass in obesity increases production of leptin, soluble leptin receptors (LEPRs, the main leptin binding proteins in circulation that result from LEPR cleavage and regulate leptin function and bioavailability) decrease, while leptin transport into the central nervous system (CNS) is not commensurately increased, resulting in decreased hypothalamic leptin signaling, increased leptin levels and leptin resistance [ 47 , 48 , 49 , 50 ]. Adiponectin, another adipocyte-specific hormone, actually the most abundant adipocytokine in plasma and ubiquitously expressed in adipose tissue [ 10 ], displays anti-inflammatory and antifibrotic properties in many organs [ 51 , 52 , 53 ].…”
Section: Adipose Tissue Physiologymentioning
confidence: 99%
“…Chronic hypersecretion of stress mediators, such as glucocorticoids, may result in insulin and leptin hypersecretion, contributing to insulin and leptin resistance, along with dysregulation of appetite and food intake by inducing alterations in the reward system, finally leading to obesity [ 86 ]. Also, overexpression of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) resulting in increased conversion to active cortisol, has been associated with central obesity because of increased activity in the adipose tissue of obese adult females [ 48 ]. Importantly, the offspring of obese mothers display a higher baseline cortisol, resulting in a dysregulated stress response and predisposition to metabolic dysfunction [ 48 ].…”
Section: Child and Adolescent Obesitymentioning
confidence: 99%
See 2 more Smart Citations
“…A r t i c l e (45)(46)(47)(48) Increased podocyte injury (29) Glomerulomegaly & glomerulosclerosis (29) Excessive tubular sodium reabsorption (49)(50)(51) Increased sympathetic activity (29) Increased RAAS activity (47,51) Metabolic effects Abnormal lipid metabolism (52,53,73) Adipokine dysregulation (54)(55)(56)(57)(58)(59)(60)(61)(62)(63)(64)(66)(67)(68)(69) Increased insulin resistance (64,65) Increased inflammation (70,71,73) Increased oxidative stress (73,74) Lipid nephrotoxicity Excessive renal fat accumulation (70)(71)(72) Glomerular and tubular cell injuries (71)(72)(73) Mitochondrial dysfunction, oxidative stress & inflammation (71,73,74) Increased FFA toxicity to proximal tubu...…”
Section: A C C E P T E Dmentioning
confidence: 99%